The compiler infers, but does not take instructions. There is no syntax for explicit type declarations yet, and the new type ...

A generic version of a breakthrough cystic fibrosis drug, manufactured in Bangladesh for a fraction of the American price, ...

Project Valhalla's JEP 401 will bring value classes to JDK 28, removing object identity from Java types in a 197,000-line change twelve years in the making ...

Viatris' improving sales trends and margins combined with meaningful development opportunities could help boost its valuation multiple. Viatris combines stable cash flow from established drugs with a ...

Some Canadians will be able to buy brand-name GLP-1 drug Ozempic at a reduced price, Danish drugmaker Novo Nordisk said in a statement Tuesday. The move comes as two generic versions of Ozempic and ...

Hims & Hers Health (HIMS) on Thursday announced the launch of generic versions of Novo Nordisk’s (NVO) blockbuster GLP-1 therapy semaglutide through its telehealth platform in Canada. The ...

The Trump administration is joining forces with Mark Cuban’s Cost Plus Drugs, Amazon Pharmacy, and GoodRx to add generic medications to the direct-to-consumer drug sales website, TrumpRx, in an ...

WASHINGTON, May 18 (Reuters) - U.S. President Donald Trump said on Monday that TrumpRx.gov, a government-backed website that lists discounted prescription drugs, will begin featuring generic medicines ...

US Drugs Site TrumpRx to List 600 Generics as Trump Targets Lower Prices By Steve Holland and Ahmed Aboulenein WASHINGTON, May 18 (Reuters) - U.S. ⁠President ⁠Donald Trump said on Monday ⁠that TrumpRx ...

Mojang recently released a brand new friends list feature for Minecraft Java Edition. Previously, only Bedrock Edition gave you the option to send friend requests and add friends to the game. This ...

The latest Minecraft Java snapshot is out now, and it introduces an array of new items and ambient entities like music discs. Apart from these, the developers have added a new Friends List and Peer-to ...

Patent expiry across API, formulation, and device IP is expected to catalyze biosimilar competition, expanding access while compressing pricing across pharmaceutical and device value chains.